|
AVTX Avalo Therapeutics Inc 1534120 |
| Balance Sheet |
|
Current Assets
|
$88,825,000.00 |
|
Assets
|
$99,885,000.00 |
|
Current Liabilities
|
$11,599,000.00 |
|
Liabilities
|
$31,565,000.00 |
|
Equity
|
$68,320,000.00 |
|
Shares Out
|
24637807.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-17,691,000.00 |
|
Investing Cash Flow
|
$25,505,000.00 |
| Market Analysis |
Market Cap
|
$477,727,077.73 |
|
Price
|
$18.07 |
|
BVPS
|
2.77 |
|
PB
|
7.00 |
|
EPS
|
-0.98 |
|
PS
|
7867.39 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:27 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:23 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AVTX documents filed with the SEC.
AVTX Filings
Clear
